Radioimmunotherapy with alpha-particle-emitting immunoconjugates

Science. 1988 May 20;240(4855):1024-6. doi: 10.1126/science.2897133.

Abstract

Alpha particles are energetic short-range ions whose higher linear energy transfer produces extreme cytotoxicity. An alpha-particle-emitting radioimmunoconjugate consisting of a bismuth-212-labeled monoclonal immunoglobulin M specific for the murine T cell/neuroectodermal surface antigen Thy 1.2 was prepared. Analysis in vitro showed that the radioimmunoconjugate was selectively cytotoxic to a Thy 1.2+ EL-4 murine tumor cell line. Approximately three bismuth-212-labeled immunoconjugates per target cell reduced the uptake of [3H]thymidine by the EL-4 target cells to background levels. Mice inoculated intraperitoneally with EL-4 cells were cured of their ascites after intraperitoneal injection of 150 microcuries of the antigen-specific radioimmunoconjugate, suggesting a possible role for such conjugates in intracavitary cancer therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Alpha Particles*
  • Animals
  • Antigens, Surface*
  • Bismuth / therapeutic use
  • Immunoglobulin M*
  • Immunotherapy
  • Lymphoma / radiotherapy*
  • Mice
  • Mice, Inbred C57BL
  • Radioisotopes / therapeutic use
  • Thy-1 Antigens

Substances

  • Antigens, Surface
  • Immunoglobulin M
  • Radioisotopes
  • Thy-1 Antigens
  • Bismuth